MET and cancer: However, the transcriptional control by factors such as hypoxia-inducible factor or NF-ƙB can only partially explain the pervasive overexpression of MET in cancer, highlighting the need for additional mechanisms supporting the MET oncogene inducible nature (De Bacco et al, 2011; Pennacchietti et al, 2003).